Summary. Supernatants from short-term 
Introduction
Implantation of the blastocyst in the maternal uterus induces the differentiation of endometrial cells to form the decidual tissue of pregnancy. Many functions have been attributed to this tissue, including nutrition of the embryo, an endocrinological role, and as a barrier to trophoblast invasion (see Finn, 1971 ). More recently, various immunological effects have been reported to be associated with the decidua and many cells bearing markers associated with immunologically active cells have now been identified in this tissue (see Bell, 1983) . The extent of the development of decidualization in the mouse is dependent upon antigenic differences between the maternal and paternal strains and also on the reproductive history and immunological status of the mother (Hetherington, 1972; Hetherington & Humber, 1975) .
During implantation in the mouse the embryo is surrounded by immunoglobulins, which are localized later on immunoglobulin-binding cells within the decidua (Bernard, Ripoche & Bennett, 1977 ). Many authors have described Fc receptor-bearing cells (Bernard, Scheid, Ripoche & Bennett, 1978; Rachman, Bernard, Scheid & Bennett, 1981 ;  Kirkwood, 1981) , which appear to be present in the decidua in different proportions, dependent upon the stage of pregnancy. Later in pregnancy, la antigen-and complement receptor-bearing cells have also been identified in the decidua basalis (Jenkinson & Searle, 1979;  Kirkwood, 1981 ;  Searle, Beli & Billington, 1983) . Allogeneic grafts transplanted to uteri of early pregnant or pseudopregnant rats, when decidual tissue could develop beneath them, and to deciduoma-containing rabbit uteri, survived significantly longer than grafts placed in the uteri of cyclic rats or elsewhere in the body (Beer & Billingham, 1974;  Dodd, Andrew & Coles, 1980 (Antebi, Bauminger, Zor & Lindner, 1975; Globerson, Bauminger, Abel & Peleg, 1976) . These observations support the contention that the decidua may fulfil an important role in maternal-fetal immunological inter¬ actions (Beer & Billingham, 1974; Hetherington & Humber, 1975; Bell, 1979a Bell, , 1983 .
Supernatants from cultures in which decidual cells arise in vitro by differentiation from uterine stem cells (Bell & Searle, 1981) (Bell & Searle, 1981; Kirkwood, 1981 (Bell & Searle, 1981 (Table 2b ). Increasing the seeding density reduced the inhibitory activity of supernatants, but reduction of the cell number slightly enhanced the degree of inhibition (Table 2c ). Fig. 1 ), the cytoplasmic and nuclear area of which increased after 48 h in culture when prepared from decidual tissue on Days 4-6 (nuclear areas: Day 4,140 ± 40pm2; Day 5, 390 ± 210pm2; Day 6,530 ± 200 pm2). Small numbers of flat dendritic cells achieved nuclear areas of 1700 pm2, similar to the decidual cells arising by invitro differentiation (Bell & Searle, 1981) . The second population was represented by small round cells, diameter 7-10 pm, which did not alter during culture, and comprised 15-20% of the cell numbers (PI. 1, Figs 1-3) . A third minor population was observed in cultures obtained from Day 8 to 11 decidual tissue, which were flat and ovoid, and whose nuclear and cytoplasmic area greatly enlarged over this period (PI. 1,  Figs 2 & 3) .
Discussion
The results of the present study demonstrate that supernatants obtained from short-term cultures (up to 48 h) of decidual tissue isolated from uteri of syngeneically mated mice can suppress the recognition and proliferation responses of lymphocytes in the MLR. The level of suppression varied with the gestational age of the tissue, being maximal with decidual tissue obtained on Day 8 of pregnancy, the period of maximal development of the decidua in vivo (Finn, 1971) . The factors in the supernatants do not exhibit immunological specificity with respect to the histocompatibility antigen system since they are also inhibitory in a third party MLR assay, and their production by decidual tissue obtained from syngeneically mated females suggests that it is an inherent property of decidual tissue rather than induced by exposure to foreign histocompatibility antigens of the fetus. It would therefore appear that these non-specific factors would be produced by decidual tissue irrespective of the genotype of the paternal strain.
The inhibition of the MLR was not due to toxicity of the decidual tissue culture supernatants, as shown by the lack of effect on lymphocyte viability during culture. The MLR is comprised of an initial antigen recognition by the responder lymphocyte population followed by its subsequent proliferation. The observation that substantial inhibition of the MLR is still achieved by addition of the supernatants after the recognition phase (i.e. after 12 h) suggests that a major action of the factor(s) is the inhibition of subsequent lymphocyte proliferation. Supernatants also produce inhibition of mitogen-induced lymphocyte proliferation and thymocyte proliferation (Badet, Bell & Billington, 1983) and, as shown in the present study, inhibition of lymphocyte proliferation as detected by inhibition of syngeneic cultures (Table 1) . However, supernatants are also able to inhibit the recognition phase of the MLR because (1) the level of inhibition of the MLR (i.e. due to recognition and proliferation) in almost all cases exceeds the level of inhibition of syngeneic cultures (i.e. due to proliferation alone) and, (2) factors responsible for inhibition of lymphocyte and thymocyte proliferation are separable from MLR inhibitory factors (Badet et al., 1983) .
In the present study the maximum inhibition observed in the MLR was 50% and it remains to be determined whether the generation of cytotoxic cells in the MLR is similarly affected. In normal murine pregnancy, anti-paternal specific cytotoxic cells are reported to be rare or absent (Smith, Burton, Barg & Mitchell, 1978; Wegmann, Waters, Drell & Carlson, 1979; Gottesman & Stutman, 1980) and anti-paternal humoral immune responses are restricted to a few inbred strains (Kaliss, 1973; Bell & Billington, 1980 ,1981 . Non-specific inhibitory factors produced locally from decidual tissue could provide an explanation for such observations (see Billington & Bell, 1982) .
It is apparent that at least two morphologically distinct cell populations are present in the shortterm decidual cultures, analogous to those observed in an in-vitro decidual cell differentiation system (Bell & Searle, 1981) , which possess characteristic cell surface markers. The flat dendritic cells, which undergo dramatic alterations in cytoplasmic and nuclear area, not only during culture but with increasing gestational age of the tissue, express maternal histocompatibility antigens and lack surface Fc receptors and immunoglobulin (Searle et al., 1983) . A sub-population of these cells appears to express la antigens from Day 14 of pregnancy (Jenkinson & Searle, 1979; Searle et al., 1983) . Of the second population of small round cells, at least a proportion appear to express Fc receptors (Kirkwood, 1981) and possess macrophage-like characteristics (Searle et al., 1983) , and are probably identical to Fc receptor-bearing cells identified in decidual tissue suspensions (Bernard et al., 1978) . It has been suggested that these small round cells represent a cellular infiltrate, recruited into the decidua during decidualization (Bell, 1983) , whereas the former population is of true decidual cells arising by differentiation of stromal fibroblasts in situ (Bell & PLATE 1 Decidual cells explanted from mice on Days 6, 8 or 9 of pregnancy, seeded at 1 10s cells/well and examined after 48 h in culture (see 'Materials and Methods'). Fig. 1 Fig. 3 . Explanted at Day 9 of pregnancy. Note dramatic increase in nuclear area of ovoid cells (see Fig. 2 ). Arrows indicate the small round cells, 244.
(Facing p. 356) Searle, 1981) . Which of these cell populations is responsible for the production of the active component(s) of culture supernatants is unknown, although there is evidence that it is a cellular infiltrate in the decidua. Cells originally identified in the draining lymph nodes, which produce a soluble non-specific immunosuppressive substance (Clark & McDermott, 1978; Clark, McDermott & Szewczuk, 1980) , have also been detected in decidual tissue (Clark & McDermott, 1981) and may constitute a proportion of the small round cells observed in the cultures. The nature and rela¬ tionships of these soluble factors to other decidual tissue products (Umapathysivam & Jones, 1978 ; Bell, 1979b; Rosenberg, Maslar & Riddick, 1980; Sutcliffe, Bolton, Sharp, Nicholson & MacKinnon, 1980) is unknown, but appear to be associated with two protein fractions (Badet et al., 1983) .
It is clear that decidual tissue during short-term in-vitro culture produces soluble factors, the production of which reflects the development of the decidua in vivo, and which exhibit the capacity to effect a partial afferent blockade of an in-vitro analogue of the cell-mediated immune response. These results not only suggest that the production of the factors observed in cultures of uterine cells in which decidual cell differentiation occurs (Kirkwood & Bell, 1981) are also produced in vivo, but support the in-vivo transplantation studies (Beer & Billingham, 1974; Dodd et al., 1980) showing that decidual tissue can partly block the rejection of intrauterine skin allografts. The fact that MLR inhibitory factors have not been detected in the peripheral serum of the pregnant mouse (Smith, 1978) suggests that these factors may operate locally at the decidua-placental interface and/or at the local draining lymph nodes to prevent proliferation, and possibly differentiation, of allosensitized lymphocytes, and be produced by migratory cells moving between the draining lymph nodes and the developing decidua. All viviparous animals bearing histoincompatible embryos face the problem of circumventing the immune responses which ensure the elimination of non-self, but the mechanisms that have evolved to achieve this may be multi-factorial and vary in individual species (Billington & Bell, 1982) . The production in many mammals of decidual tissue beneath the implanting embryo, which may fulfil many functions in pregnancy, not only provides an ideal site for the production of such non-specific immunosuppressive factors involved in the protection of the fetal allograft, but links their production to pregnancy irrespective of the particular genetic status of the fetus.
